TRAIL, when used as an alternative anticancer agent, can induce cell apoptosis in various cancers but without any cytotoxic effects on normal cells; therefore, it has been considered as a promising novel target for anticancer treatment 19, 20, 21. The gene discussed is TNFSF10; the disease is cancer.